Morgan Stanley Maintains Overweight on Docebo, Lowers Price Target to $65
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Josh Baer maintains an Overweight rating on Docebo (NASDAQ:DCBO) but lowers the price target from $67 to $65.

April 19, 2024 | 5:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley maintains an Overweight rating on Docebo but lowers the price target from $67 to $65.
The adjustment in price target by a major analyst like Morgan Stanley can influence investor sentiment, potentially leading to short-term price fluctuations. However, the maintenance of an Overweight rating indicates a continued positive outlook on the company, suggesting that the impact might be neutral to slightly positive in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100